Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Scott Gottlieb New York
Patients who take b blockers before coronary artery bypass surgery can increase their odds of surviving, a new study says.
The study found that 2.8% of patients who took b blockers before surgery died within a month, compared with 3.4% of patients who did not take the drugs (odds ratio 0.80 (95% confidence interval 0.78 to 0.82)).
Patients on b blockers also spent less time on mechanical ventilation after surgery and were less likely to require a follow up operation or to have kidney failure. The results are based on an analysis of hospital records of nearly 630 000 patients who had bypass surgery at 497 hospitals in the United States and Canada between 1996 and 1999 (JAMA 2002;287:2221-7).
Randomised clinical trials have proved the effectiveness of b blockers in improving outcomes in heart patients in general and in patients undergoing other
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
UK medical students have published unreleased government plans to restrict failed asylum seekers' access to medical care